Your browser doesn't support javascript.
loading
Gut Microbiota in Monozygotic Twins Discordant for Parkinson's Disease.
Bolliri, Carlotta; Fontana, Alessandra; Cereda, Emanuele; Barichella, Michela; Cilia, Roberto; Ferri, Valentina; Caronni, Serena; Calandrella, Daniela; Morelli, Lorenzo; Pezzoli, Gianni.
Afiliación
  • Bolliri C; Fondazione Grigioni per il Morbo di Parkinson, Milan, Italy.
  • Fontana A; Clinical Nutrition Unit, ASST-Pini-CTO, Milan, Italy.
  • Cereda E; Department for Sustainable Food Process (DiSTAS), Università Cattolica del Sacro Cuore, Cremona, Italy.
  • Barichella M; Clinical Nutrition and Dietetics Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Cilia R; Fondazione Grigioni per il Morbo di Parkinson, Milan, Italy.
  • Ferri V; Clinical Nutrition Unit, ASST-Pini-CTO, Milan, Italy.
  • Caronni S; Fondazione IRCCS Istituto Neurologico Carlo Besta, Parkinson and Movement Disorders Unit, Milan, Italy.
  • Calandrella D; Fondazione Grigioni per il Morbo di Parkinson, Milan, Italy.
  • Morelli L; Clinical Nutrition Unit, ASST-Pini-CTO, Milan, Italy.
  • Pezzoli G; Fondazione Grigioni per il Morbo di Parkinson, Milan, Italy.
Ann Neurol ; 92(4): 631-636, 2022 10.
Article en En | MEDLINE | ID: mdl-35852145
ABSTRACT
Differences in gut microbiota between Parkinson's disease patients and controls seem to depend on multiple-frequently unmeasured-confounders. Monozygotic twins offer a unique model for controlling several factors responsible for interpersonal variation in gut microbiota. Fecal samples from 20 monozygotic twin pairs (n = 40) discordant for Parkinson's disease were studied (metagenomic shotgun analysis). Paired data analysis detected minimal differences in bacterial taxa abundance at species level (Bacteroides pectinophilus [p = 0.037], Bifidobacterium pseudocatenulatum [p = 0.050], and Bifidobacterium catenulatum [p = 0.025]) and in predicted metabolic pathways (primary bile acid biosynthesis [p = 0.037]). Additional studies are warranted to understand the role of gut microbiota in the pathogenesis of Parkinson's disease. ANN NEUROL 2022;92631-636.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Microbioma Gastrointestinal Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Ann Neurol Año: 2022 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Microbioma Gastrointestinal Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Ann Neurol Año: 2022 Tipo del documento: Article País de afiliación: Italia